(Please note that all articles are collected from sites outside of VABC. If you wish for your story to be removed from this site, please contact us.)
The Neuroscience Institute of Cincinnati is starting the Brain Tumor Center with an expected $26 million in investment over 10 years.
The bulk of the financial commitment will be shared by University Hospital, the University of Cincinnati and several neuroscience-related physician practices. Community donors are expected to raise the remaining $8.5 million needed.
The money will endow clinical and research programs, fund the purchase of new technologies and accelerate collaboration among scientists and physicians.
The Brain Tumor Center will be affiliated with the UC Barrett Cancer Center at University Hospital and the joint cancer program, a cooperative initiative of UC, University Hospital and Cincinnati Children’s Hospital Medical Center.
“The Brain Tumor Center is a tremendous example of strong collaboration between University Hospital and UC to care for the residents of our community and the world beyond,” Lee Ann Liska, executive director of University Hospital, said in a press release. “This multimillion-dollar investment will enable us to recruit additional clinicians and researchers and broaden services to our patients.”
Dr. John Tew, clinical director of the UC Neuroscience Institute, added: “This infusion of funds will propel brain tumor research and care in Cincinnati to a new level of excellence while inspiring broad collaboration. It will ensure that the UC Neuroscience Institute can continue to inspire the best and brightest scientists and physicians in our quest to provide better treatments — and cures — for people with brain tumors.”
The Brain Tumor Center cares for patients with all types of brain tumor. It includes specialists from the Mayfield Clinic and several UC College of Medicine departments, including neurosurgery, radiology, radiation oncology, otolaryngology, internal medicine and physical medicine and rehabilitation.
About 215,000 brain tumors will be diagnosed in the United States this year. Of those, about 45,000 will be primary brain tumors, which originate from cells located within the brain. About 170,000 will be metastatic tumors, which develop when cancer cells from another part of the body travel through the bloodstream to the brain. Eighty percent of all brain tumors are malignant.